OOIR: Observatory of International Research

Papers

(The median citation count of Health Economics Policy and Law is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
HEP volume 17 issue 4 Cover and Back matter	57
Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges	18
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysis	16
Fellow travellers in transformative times: a reflection on 21 years membership of the European Health Policy Group	15
Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals	12
New governance of the digital health agency: a way out of the joint decision trap to implement electronic health records in Germany?	11
From speculative to real: community attitudes towards government COVID-19 vaccine mandates in Western Australia from May 2021 to April 2022	10
Politics in all policies: how healthcare is shaped by political (in)action	9
Judicial claims for access to treatment in the private health insurance sector in Brazil	8
Managed competition in Colombia: convergence of public and private insurance and delivery	8
Out with the old…	7
HEP volume 17 issue 2 Cover and Front matter	7
Saving children's lives through interventions: a quasi-experimental analysis of GAVI	7
HEP volume 16 issue 4 Cover and Front matter	6
Institutional boundaries and the challenges of aligning science advice and policy dynamics: the UK and Canada in the time of COVID-19	6
A review of heath economic evaluation practice in the Netherlands: are we moving forward?	5
Making care primary: a renewed investment into primary care	5
An examination of health care efficiency in Canada: a two-stage semi-parametric approach	4
Preconditions for efficiency and affordability in mixed health systems: are they fulfilled in the Australian public–private mix?	4
Value-based evidence across health care sectors: a push for transparent real-world studies, data, and evidence dissemination	4
Fair processes for financing universal health coverage?	4
Healthcare reform in the Netherlands: after 15 years of regulated competition	3
Neighborhood inequalities and the decline of infant mortality in São Paulo	3
Medical marijuana laws and mental health in the United States	3
Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework	3

The state of American health coverage: the 2022 elections and the Affordable Care Act	3
Exploring differences between public and private providers in primary care: findings from a large Swedish region	3
Primary care as determinant of COVID-19 and influenza vaccine uptake	3
HEP volume 17 issue 1 Cover and Front matter	3
Does Medicaid expansion influence county health spending? A case of New York counties	3
Financial risk protection in private health insurance: empirical evidence on catastrophic and impoverishing spending from Germany's dual insurance system	3
The roads to managed competition for mixed public–private health systems: a conceptual framework	3
Political determinants of health: (re) examining the role of governance in reducing maternal mortality	2
Has regional decentralisation saved lives during the COVID-19 pandemic?	2
Accelerating integration of social needs into mainstream healthcare to achieve health equity in the COVID-19 era	2
Health misinformation and freedom of expression: considerations for policymakers	2
Navigating conflicting expectations in addressing healthcare scarcity: a q-methodology study on the Dutch National Health Care Institute	2
… and in with the new	2
Response to critics of Open and Inclusive: Fair Processes for Financing Universal Health Coverage	2
Private equity involvement in primary care: the case of Ireland	2
Privatising, liberalising and dividing a welfare state without affecting universality? Debunking the myths surrounding the rapid rise of private health insurance in Sweden	2
Do consumers perceive and trust health insurers within a system of managed competition as prudent buyers of care?	2
Successfully changing the mode of regulation in clinical priority setting: how organisational factors contributed to establishing the Norwegian priority guidelines for specialist health care services	2
Early child health in Africa: do ICT and democracy matter?	2
Why procedural fairness is essential to financing universal health coverage	2
Managed competition in the United States: How well is it promoting equity and efficiency?	1
Past experiences with surprise medical bills drive issue knowledge, concern and attitudes toward federal policy intervention	1
Pandemic preparedness and response: a new mechanism for expanding access to essential countermeasures	1
Reforming the funding of long-term care for older people: costs and distributional impacts of planned changes in England	1
A systematic literature review of real-world evidence (RWE) on post-market assessment of medical devices	1
Improving access to healthcare in Ireland: an implementation failure	1
Integrated care in a Beveridge system: experiences from England and Denmark	1
‘Nurses are seen as general cargo, not the smart TVs you ship carefully’: the politics of nurse staffing in England, Spain, Sweden, and the Netherlands	1
Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit	1
The still incomplete pursuit of universal access to medicines	1
Need, demand, supply in health care: working definitions, and their implications for defining access	1
Regulated markets and rationalised myths: an institutional perspective on value-based purchasing in the Netherlands	1
If you were a policymaker, which treatment would you disinvest? A participatory value evaluation on public preferences for active disinvestment of health care interventions in the Netherlands	1
Managed competition in Aotearoa New Zealand: past experiences and future prospects	1
Public health by organizational fix?	0
Success and failure in establishing national physician databases: a comparison between Canada and Israel	0
Précis of Open and Inclusive: Fair Processes for Financing Universal Health Coverage	0
What is a ‘National’ ‘Health’ ‘Service’? A keyword analysis of policy documents leading to the formation of the UK NHS	0
Enhancing procedural fairness: a critique of the open and inclusive approach to health financing decisions	0
HEP volume 17 issue 3 Cover and Back matter	0
Just a question of time? Explaining non-take-up of a public health insurance program designed for undocumented immigrants living in France	0
Value assessment and decision-making: how to move health systems forward?	0
Roadmaps to managed competition: to what extent does South Africa meet the preconditions for equity and efficiency?	0
US public opinion about interior border checkpoints and health care access for undocumented immigrants	0
Effects of public long-term care insurance on the medical service use by older people in South Korea	0
Exploring the uptake of economic evaluation in Spanish reports positioning medicines for public reimbursement	0
High-risk individuals in voluntary health insurance markets: the elephant in the room?	0
Health care reform and financial crisis in the Netherlands: consequences for the financial arena of health care organizations	0
Why did England change its law on deceased organ donation in 2019? The dynamic interplay between evidence and values	0
Procedural fairness to recalibrate the power imbalance in health decision-making: comment on the report: ‘Open and inclusive: Fair processes for financing universal health coverage’	0

The relationship between enrollees’ perceptions of health insurers’ tasks and their trust in them	0
Soft law and individual responsibility: a review of the Swedish policy response to COVID-19	0
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment	0
Spillover effects of financial incentives for providers onto non-targeted patients: daycase surgery in English hospitals	0
Emergency care reconfiguration in the Netherlands: conflicting interests and trade-offs from a multidisciplinary perspective	0
Unveiling Medicaid fraud and abuse: the influence of price transparency and state political context	0
Implications of the fair processes for financing UHC report for development assistance: reflections and an application of the decision-making principles to PEPFAR	0
Consolidating political leadership in healthcare: a mediating institution for priority-setting as a political strategy in a local health system	0
Navigating health systems in times of inequality and uncertainty… And how we go from here	0
Special issue: On the roof top of health policy change: overlooking 21 years of the European Health Policy Group	0
The effects of a sugar-sweetened beverage tax: moving beyond dental health outcomes and service utilisation	0
Strengthening health system governance in Germany: looking back, planning ahead	0
How reforms hamper priority-setting in health care: an interview study with local decision-makers in London	0
HEP volume 17 issue 2 Cover and Back matter	0
Coping with COVID-19: the role of hospital care structures and capacity expansion in five countries	0
What's the ideal World Health Organization (WHO)?	0
Is the emergency department used as a substitute or a complement to primary care in Medicaid?	0
How should medicines reimbursement work? The views of Spanish experts	0
Learning lessons from the COVID-19 pandemic	0
Lead-attributable productivity losses in low- and middle-income countries	0
Understanding public procurement within the health sector: a priority in a post-COVID-19 world	0
Pricing of hospital services: evidence from a thematic review	0
The inefficient effects of non-clinical factors on health care costs	0
Time for a paradigm shift? Exploring competition regulation and its relationship with the rising global burden of industrial epidemics	0
HEP volume 17 issue 1 Cover and Back matter	0
The forgotten dimension of integrated care: barriers to implementing integrated clinical care in English NHS hospitals	0
HEP volume 17 issue 4 Cover and Front matter	0
Health insurance and fertility among low-income, childless, single women: evidence from the ACA Medicaid expansions	0
Just informal patient payments are not enough, ‘personal connections’ and knowledge of the ‘rules’ are also required: a logistic regression analysis of informal practices in health care in Ukraine	0
Including carer health-related quality of life in NICE health technology assessments in the United Kingdom	0
Balancing between competition and regulation in healthcare markets	0
Virtual reality evidence on the impact of physicians' open versus defensive communication on patients	0
The normative grounds for NICE decision-making: a narrative cross-disciplinary review of empirical studies	0
Any lessons to learn? Pathways and impasses towards health system resilience in post-pandemic times	0
The impact of surprise billing laws on hospital-based physician prices and network participation	0
Strengthening primary health care in China: governance and policy challenges	0
HEP volume 17 issue 3 Cover and Front matter	0
Changing roles of health insurers in France, Germany, and the Netherlands: any lessons to learn from Bismarckian systems?	0
HEP volume 16 issue 4 Cover and Back matter	0
The prevalence and consequences of support for off-label Ozempic prescriptions	0
The roadmaps to managed competition: theory and practice	0
Globalisation and mental health: is globalisation good or bad for mental health? Testing for quadratic effects	0
Publicly funded health insurance schemes and demand for health services: evidence from an Indian state using a matching estimator approach	0
Learning lessons about lesson-learning: Covid complexity	0
Impact on the NHS and health of the UK's trade and cooperation relationship with the EU, and beyond	0
Understanding household healthcare expenditure can promote health policy reform	0
Structuring complexity? A systemic perspective on the implementation of a disease management programme for type II diabetes care in Denmark	0
Safety of scientific medical research is a State obligation	0